IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (AMEX: COR, http://www.cortexpharm.com) reported a net loss of $2,962,000, or $0.07 per share for the quarter ended September 30, 2007 compared with a net loss of $3,635,000, or $0.10 per share for the corresponding prior year period. Non-cash stock-based compensation charges for the quarter ended September 30, 2007 and 2006 were approximately $635,000 and $731,000, respectively.
